Chamber and committees

I refer the member to the answer to question S6W-30309 on 28 October 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-30309 on 28 October 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-30309 on 28 October 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The safer drug consumption facility is targeted at reducing drug-related harms. In countries where drug consumption rooms already operate, they have seen a drop in drug-related issues within the vicinity of the site. International literature suggests there is no increase in drug-related crime around these facilities but we are not aware of the measurement of non-drug related crime.

Glasgow Health and Social Care Partnership plan to assess the impact of the opening of the safer drug consumption facility on the local community, including experiences of crime and perceptions of local safety as part of the formal evaluation, led by Public Health Scotland academics. This work is being informed by consultation with the local community.

Substances used within the service are procured by the individuals using the service and not by the service itself. The Lord Advocate indicated in September 2023 that she would be prepared to publish a statement of prosecution policy to the effect that it would not be in the public interest to prosecute users of the facility in terms of section 5(2) of the Misuse of Drugs Act 1971 for simple possession offences committed within the confines of the safer drug consumption facility. This does not apply to the staff. No substances have been or will be purchased, and therefore there are no associated costs.

The SDCF website contains information on the service and highlights that those attending the service ‘can only use the drug they bring onto the site’.

Work on the establishment of a safer drug consumption facility in Glasgow by the Scottish Government has been undertaken through the Harm Reduction team in the Drugs Policy Division. The work has been led by a C1 (£57,141–£71,243) supported by a B3 (£45,449–£54,419).

I refer the member to the answer to question S6W-30309 on 28 October 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-30309 on 28 October 2024. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Migraine Trust were awarded £85,675 in 2022-23 through the Scottish Government Neurological Care & Support Framework, for work upskilling community, primary and secondary care pharmacists across NHS Grampian to help people with migraine manage their symptoms and treatments more effectively.

The Scottish Government funded an additional £135,501 in 2023-24 to further embed this work locally, and to partner with other Health Boards to extend the reach of pharmacists trained and increase care and support for people living with migraine based on the blueprint NHS Grampian approach.

We understand that a further six NHS Boards are working towards adopting this model of migraine care in future, including NHS Lanarkshire, NHS Lothian & NHS Tayside who have project teams in place with plans to undertake work with support from the NHS Grampian/Migraine Trust project team.

An eLearning programme for NHS Education for Scotland’s platform TURAS has been developed through the project. This comprises a suite of training materials available for all pharmacists and pharmacy teams in Scotland to access.

The project in Grampian has forged links with Robert Gordon University’s School of Pharmacy and Life Sciences with the aim of helping to shape students’ learning, towards create a sustainable change to the way migraine care is given.

We receive regular progress updates from the Migraine Trust and myself visited the project in August. We are discussing options with the Migraine Trust for further adoption of this approach to delivering care for people with migraine.

The Scottish Government is working with Public Health Scotland to review options in relation to collecting data on secondary breast cancer in Scotland. This includes consideration of the NHS England audit, data available in Scotland, clinical time required, other cancer data priorities and how it can be used to improve services. We are aiming to agree the best method of data collection by the end of the current Cancer Action Plan in March 2026.